Skip to main content

CONMED Corporation (CNMD)

NYSE: CNMD · IEX Real-Time Price · USD
135.08 -7.37 (-5.17%)
Nov 26, 2021 1:00 PM EST - Market closed
Market Cap3.95B
Revenue (ttm)989.49M
Net Income (ttm)62.24M
Shares Out29.25M
EPS (ttm)1.94
PE Ratio69.81
Forward PE38.02
Dividend$0.80 (0.59%)
Ex-Dividend DateSep 14, 2021
Volume432,652
Open146.83
Previous Close142.45
Day's Range134.91 - 141.84
52-Week Range97.95 - 159.11
Beta1.56
AnalystsBuy
Price Target160.60 (+18.9%)
Earnings DateOct 27, 2021

About CNMD

CONMED Corporation, a medical technology company, develops, manufactures, and sells surgical devices and related equipment for minimally invasive procedures worldwide. It offers orthopedic surgery products, including sports medicine products comprising powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, and metal and bioabsorbable implants, as well as related disposable products and fluid management systems; powered surgical instruments for use in bone orthopedic, arthroscopic, oral/maxillofacial, podiatric,...

IndustryHealth Care Equipment & Supplies
IPO DateJul 23, 1987
CEOCurt Hartman
Employees3,400
Stock ExchangeNYSE
Ticker SymbolCNMD
Full Company Profile

Financial Performance

In 2020, CNMD's revenue was $862.46 million, a decrease of -9.70% compared to the previous year's $955.10 million. Earnings were $9.52 million, a decrease of -66.75%.

Financial Statements

Analyst Forecast

According to 6 analysts, the average rating for CNMD stock is "Buy." The 12-month stock price forecast is 160.60, which is an increase of 18.89% from the latest price.

Price Target
$160.60
(18.89% upside)
Analyst Consensus: Buy

News

Why Conmed (CNMD) is a Top Growth Stock for the Long-Term

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

1 week ago - Zacks Investment Research

CONMED Corporation to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Preside...

1 week ago - Business Wire

CONMED Corporation to Participate at the Stifel 2021 Virtual Healthcare Conference on November 16, 2021

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced Todd W. Garner, Executive Vice President and Chief Financial Officer, will participate in a presentation at the Stifel 2021 ...

2 weeks ago - Business Wire

HSIC or CNMD: Which Is the Better Value Stock Right Now?

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Other symbols:HSIC
3 weeks ago - Zacks Investment Research

CONMED's (CNMD) Q3 Earnings Beat Estimates, Revenues Miss

CONMED's (CNMD) third-quarter earnings reflect strong segmental performance.

4 weeks ago - Zacks Investment Research

Conmed (CNMD) Surpasses Q3 Earnings Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 3.90% and -2.51%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

1 month ago - Zacks Investment Research

Conmed: Q3 Earnings Insights

Conmed (NYSE:CNMD) reported its Q3 earnings results on Wednesday, October 27, 2021 at 04:05 PM. Here's what investors need to know about the announcement.

1 month ago - Benzinga

CONMED Corporation Announces Third Quarter Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the third quarter ended September 30, 2021. Third Quarter 2021 Highlights Sales of $248.8 million incr...

1 month ago - Business Wire

Earnings Preview: Conmed (CNMD) Q3 Earnings Expected to Decline

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

1 month ago - Zacks Investment Research

HSIC or CNMD: Which Is the Better Value Stock Right Now?

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Other symbols:HSIC
1 month ago - Zacks Investment Research

CONMED Corporation to Announce Third Quarter 2021 Financial Results on October 27, 2021

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the third quarter 2021 after the market close on October 27, 2021. The Company's m...

1 month ago - Business Wire

Here's Why You Should Retain CONMED (CNMD) Stock For Now

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

2 months ago - Zacks Investment Research

CONMED Corporation to Participate in a Virtual Fireside Chat at the Morgan Stanley Global Healthcare Conference

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that Curt R. Hartman, Chair of the Board, President, and Chief Executive Officer, and Todd W. Garner, Executive Vice Preside...

2 months ago - Business Wire

Conmed (CNMD) Down 4.4% Since Last Earnings Report: Can It Rebound?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

3 months ago - Zacks Investment Research

HSIC vs. CNMD: Which Stock Is the Better Value Option?

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Other symbols:HSIC
3 months ago - Zacks Investment Research

CONMED Corporation Announces Quarterly Cash Dividend

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that its Board of Directors has declared a quarterly cash dividend of $0.20 per share, payable on October 5, 2021 to all sha...

3 months ago - Business Wire

Here's Why You Should Retain CONMED (CNMD) Stock for Now

Investors continue to be optimistic about CONMED (CNMD) owing to its broad product spectrum.

3 months ago - Zacks Investment Research

CONMED's (CNMD) Q2 Earnings Surpass Estimates, '21 View Up

CONMED (CNMD) witnesses revenue uptick in both of its segments during Q2 despite continued pandemic-led business disruptions.

3 months ago - Zacks Investment Research

Conmed (CNMD) Tops Q2 Earnings and Revenue Estimates

Conmed (CNMD) delivered earnings and revenue surprises of 14.52% and 2.94%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

3 months ago - Zacks Investment Research

Conmed: Q2 Earnings Insights

Shares of Conmed (NYSE:CNMD) moved lower in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share increased 1114.29% year over year to $0.71, which beat the es...

3 months ago - Benzinga

CONMED Corporation Announces Second Quarter Financial Results

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced financial results for the second quarter ended June 30, 2021. Second Quarter 2021 Highlights Sales of $255.2 million increas...

3 months ago - Business Wire

Conmed (CNMD) Earnings Expected to Grow: Should You Buy?

Conmed (CNMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 months ago - Zacks Investment Research

CONMED Corporation to Announce Second Quarter 2021 Financial Results on July 28, 2021

LARGO, Fla.--(BUSINESS WIRE)--CONMED Corporation (NYSE: CNMD) today announced that it will report financial results for the second quarter 2021 after the market close on Wednesday, July 28, 2021. The Co...

4 months ago - Business Wire

Why Is Conmed (CNMD) Down 3.9% Since Last Earnings Report?

Conmed (CNMD) reported earnings 30 days ago. What's next for the stock?

5 months ago - Zacks Investment Research

HSIC vs. CNMD: Which Stock Should Value Investors Buy Now?

HSIC vs. CNMD: Which Stock Is the Better Value Option?

Other symbols:HSIC
6 months ago - Zacks Investment Research